结节性红斑

Bondi EE, Margolis DJ, Lazarus ZS. Panniculitis. In: Freedberg I, Eisen A, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. 5th ed. New York, NY: McGraw-Hill; 1999: 1284-6.

Requena L, Requena C. Erythema nodosum (review). Dermatol Online J. 2002 Jun;8(1):4. 摘要

Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000 Oct;43(4):691-7. 摘要

Friedman ES, LaNatra N, Stiller MJ. NSAIDs in dermatologic therapy: review and preview. J Cutan Med Surg. 2002 Sep-Oct;6(5):449-59. 摘要

Schultz E, Whiting D. Treatment of erythema nodosum and nodular vasculitis with potassium iodides. Br J Dermatol. 1976 Jan;94(1):75-8. 摘要

1. Bondi EE, Margolis DJ, Lazarus ZS. Panniculitis. In: Freedberg I, Eisen A, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. 5th ed. New York, NY: McGraw-Hill; 1999: 1284-6.

2. Requena L, Requena C. Erythema nodosum (review). Dermatol Online J. 2002 Jun;8(1):4. 摘要

3. Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, et al. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021 May;22(3):367-78.全文  摘要

4. Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014 Apr 16;20(4):22376.全文  摘要

5. Kakourou T, Drosatou P, Psychou F, et al. Erythema nodosum in children: a prospective study. J Am Acad Dermatol. 2001 Jan;44(1):17-21. 摘要

6. Varas P, Antúnez-Lay A, Bernucci JM, et al. [Erythema nodosum: analysis of 91 hospitalized patients]. [in spa]. Rev Med Chil. 2016 Feb;144(2):162-8.全文  摘要

7. Sota Busselo I, Oñate Vergara E, Pérez-Yarza EG, et al. [Erythema nodosum: etiological changes in the last two decades]. [in spa]. An Pediatr (Barc). 2004 Nov;61(5):403-7.全文  摘要

8. Davatchi F, Chams-Davatchi C, Shams H, et al. Behcet's disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol. 2017 Jan;13(1):57-65. 摘要

9. Leonardo NM, McNeil J. Behcet's disease: is there geographical variation? a review far from the silk road. Int J Rheumatol. 2015;2015:945262.全文  摘要

10. Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007 Jan;20(1):115-32.全文  摘要

11. Tsang CA, Anderson SM, Imholte SB, et al. Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008. Emerg Infect Dis. 2010 Nov;16(11):1738-44.全文  摘要

12. Said S, Yanuck J, Burns MJ. A case of erythema nodosum with coccidioidomycosis. Clin Pract Cases Emerg Med. 2017 Aug;1(3):251-2.全文  摘要

13. McBride JA, Gauthier GM, Klein BS. Clinical manifestations and treatment of blastomycosis. Clin Chest Med. 2017 Sep;38(3):435-49.全文  摘要

14. Cohen PR. Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine-associated erythema nodosum. Dermatol Ther (Heidelb). 2013 Dec;3(2):191-7.全文  摘要

15. Sullivan R, Clowers-Webb H, Davis MD. Erythema nodosum: a presenting sign of acute myelogenous leukemia. Cutis. 2005 Aug;76(2):114-6. 摘要

16. Bonci A, Di Lernia V, Merli F, et al. Erythema nodosum and Hodgkin's disease. Clin Exp Dermatol. 2001 Jul;26(5):408-11. 摘要

17. Akcali C, Savas L, Baba M, et al. Cutaneous manifestations in brucellosis: a prospective study. Adv Ther. 2007 Jul-Aug;24(4):706-11.全文  摘要

18. O'Connor TM, Cagney D, Jahangir A, et al. Characteristics of patients presenting with erythema nodosum and sarcoidosis. Ir Med J. 2009 Jun;102(6):181-4. 摘要

19. Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore). 2008 Sep;87(5):281-93.全文  摘要

20. Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016 Apr;10(4):429-36.全文  摘要

21. Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med. 2007 Jan 1;175(1):40-4. 摘要

22. Starba A, Chowaniec M, Wiland P. Erythema nodosum - presentation of three cases. Reumatologia. 2016;54(2):83-5.全文  摘要

23. Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000 Oct;43(4):691-7. 摘要

24. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000 Apr;161(4 pt 2):S221-47.全文  摘要

25. Gea-Banacloche JC, Opal SM, Jorgensen J, et al. Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med. 2004 Nov;32(11 suppl):S578-90. 摘要

26. Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med. 2016 May;13(5):e1002024.全文  摘要

27. Friedman ES, LaNatra N, Stiller MJ. NSAIDs in dermatologic therapy: review and preview. J Cutan Med Surg. 2002 Sep-Oct;6(5):449-59. 摘要

28. Schultz E, Whiting D. Treatment of erythema nodosum and nodular vasculitis with potassium iodides. Br J Dermatol. 1976 Jan;94(1):75-8. 摘要

29. Van Veen NH, Lockwood DN, van Brakel WH, et al. Interventions for erythema nodosum leprosum. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006949.全文  摘要

30. Kaur I, Dogra S, Narang T, et al. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study. Australas J Dermatol. 2009 Aug;50(3):181-5.全文  摘要

31. Verma KK, Srivastava P, Minza A, et al. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum. Lepr Rev. 2006 Sep;77(3):225-9. 摘要

32. Meggitt SJ, Anstey AV, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. Br J Dermatol. 2011 Oct;165(4):711-34.全文  摘要

33. Yurdakul S, Mat C, Tüzün Y, et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum. 2001 Nov;44(11):2686-92.全文  摘要

34. McEwan T, Robinson PC. A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections. Semin Arthritis Rheum. 2021 Feb;51(1):101-12.全文  摘要

35. Stewart S, Yang KCK, Atkins K, et al. Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2020 Feb 13;22(1):28.全文  摘要

36. Song JS, Halim K, Vleugels RA, et al. Dapsone for treatment of erythema nodosum. Dermatol Online J. 2016 Feb 17;22(2):13030/qt8z782742. 摘要

37. Sharquie KE, Najim RA, Abu-Raghif AR. Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study. J Dermatol. 2002 May;29(5):267-79. 摘要

38. Boyd AS. Use of mycophenolate mofetil in erythema nodosum. J Am Acad Dermatol. 2002 Dec;47(6):968-9. 摘要

39. Ying S, Li S, Tang S, et al. Immune-mediated necrotizing myopathy initially presenting as erythema nodosum. J Inflamm Res. 2020;13:471-6.全文  摘要

40. Alia E, Varma A, Brody J, et al. Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum. JAAD Case Rep. 2020 Jun;6(6):567-8.全文  摘要

41. Boyd AS. Etanercept treatment of erythema nodosum. Skinmed. 2007 Jul-Aug;6(4):197-9. 摘要

42. Kugathasan S, Miranda A, Nocton J, et al. Dermatologic manifestations of Crohn disease in children: response to infliximab. J Pediatr Gastroenterol Nutr. 2003 Aug;37(2):150-4.全文  摘要

43. Dehesa L, Abuchar A, Nuno-Gonzalez A, et al. The use of cyclosporine in dermatology. J Drugs Dermatol. 2012 Aug;11(8):979-87. 摘要

44. Chavez-Álvarez S, Gómez-Flores M, Ocampo-Candiani J. [Cutaneous manifestations in inflammatory bowel disease]. [in spa]. Gac Med Mex. 2016 Sep - Oct;152(5):622-30.全文  摘要